Similarly, a phase 1 randomized controlled trial of BIIB078 in patients with ALS (NCT03626012), another ASO targeting C9orf72 repeat-containing mRNA, did not meet primary endpoints [40]. Here, C9orf72 is linked to amyotrophic lateral sclerosis.